Roflumilast N-oxide

Modify Date: 2024-01-02 18:13:30

Roflumilast N-oxide Structure
Roflumilast N-oxide structure
Common Name Roflumilast N-oxide
CAS Number 292135-78-5 Molecular Weight 419.207
Density 1.6±0.1 g/cm3 Boiling Point 519.7±50.0 °C at 760 mmHg
Molecular Formula C17H14Cl2F2N2O4 Melting Point 181 °C
MSDS N/A Flash Point 268.1±30.1 °C

 Use of Roflumilast N-oxide


Roflumilast N-oxide is a PDE type 4 inhibitor.

 Names

Name 3-(cyclopropylmethoxy)-N-(3,5-dichloro-1-hydroxypyridin-4-ylidene)-4-(difluoromethoxy)benzamide
Synonym More Synonyms

 Roflumilast N-oxide Biological Activity

Description Roflumilast N-oxide is a PDE type 4 inhibitor.
Related Catalog
Target

PDE type 4[1]

In Vitro Roflumilast N-oxide at 2 nM partly mitigates the cigarette smoke extract (CSE)-induced epithelial to mesenchymal transition (EMT) in WD-HBEC in vitro. Roflumilast N-oxide (2 nM) reverses the compromised expression of E-cadherin transcripts following CSE by 45%. The expression of collagen type I is abrogated by Roflumilast N-oxide (2 nM). The epithelial cell phenotype appears protected when cells are co-incubated with Roflumilast N-oxide (2 nM). Pre-incubation with Roflumilast N-oxide (2 nM) also partly attenuates the nuclear translocation of β-catenin[2].
In Vivo Single treatment of db/db mice with 10 mg/kg Roflumilast N-oxide enhances plasma glucagon-like peptide-1 (GLP-1) 4-fold. Chronic treatment of db/db mice with Roflumilast N-oxide at 3 mg/kg shows prevention of disease progression. Roflumilast-N-oxide abolishes the increase in blood glucose, reduces the increment in HbA1c by 50% and doubles fasted serum insulin compare with vehicle, concomitants with preservation of pancreatic islet morphology. Furthermore, Roflumilast-N-oxide amplifies forskolin-induced insulin release in primary islets. Roflumilast-N-oxide also shows stronger glucose-lowering effects than its parent compound[3].
Cell Assay A549 cells are washed and cultured overnight in serum-free F-12 K medium supplemented with antibiotics, L-glutamine and HEPES. The starved cells are incubated with Neutrophil elastase (NE) for 30 min or vehicle (PBS), washed with PBS and then cultured in serum free F-12 K. After stimulation, cell supernatants are collected at 24 h (for cytokine measurements) and cell pellets are collected after 2 h (for mRNA expression analysis). Alternatively, A549 cells are pre-incubated for 2 h with Roflumilast N-oxide (RNO) (at 0.1 μM, 0.3 μM and 1 μM), vehicle (DMSO 0.01%) prior to the addition of NE. All experiments are performed in serum-free medium in triplicate and are repeated at least three times. At the end of the incubation period, culture supernatants are harvested and stored at -80°C until further analysis[1].
Animal Admin At 7 weeks of age, 16 h fasting mice receive a single oral dose of vehicle (4% methocel) or 10 mg/kg Roflumilast-N-oxide, and a glucose bolus of 2 g/kg body weight is co-administered as a physiological initiator for glucagon-like peptide-1 (GLP-1) secretion. Plasma GLP-1 is analyzed 60 min before, and 10 and 60 min after administration of Roflumilast-N-oxide and glucose. The effect of Roflumilast-N-oxide on plasma GLP-1 is also investigated in the absence of the glucose bolus[3].
References

[1]. Victoni T, et al. Roflumilast n-oxide associated with PGE2 prevents the neutrophil elastase-induced production of chemokines by epithelial cells. Int Immunopharmacol. 2016 Jan;30:1-8.

[2]. Milara J,et al. Simvastatin Increases the Ability of Roflumilast N-oxide to Inhibit Cigarette Smoke-Induced Epithelial to Mesenchymal Transition in Well-differentiated Human Bronchial Epithelial Cells in vitro. COPD. 2015 Jun;12(3):320-31.

[3]. Vollert S, et al. The glucose-lowering effects of the PDE4 inhibitors roflumilast and roflumilast-N-oxide in db/db mice. Diabetologia. 2012 Oct;55(10):2779-2788.

 Chemical & Physical Properties

Density 1.6±0.1 g/cm3
Boiling Point 519.7±50.0 °C at 760 mmHg
Melting Point 181 °C
Molecular Formula C17H14Cl2F2N2O4
Molecular Weight 419.207
Flash Point 268.1±30.1 °C
Exact Mass 418.029877
PSA 73.05000
LogP 1.43
Vapour Pressure 0.0±1.4 mmHg at 25°C
Index of Refraction 1.616

 Synonyms

3-(Cyclopropylmethoxy)-N-(3,5-dichloro-1-oxido-4-pyridinyl)-4-(difluoromethoxy)benzamide
Roflumilast N-oxide
UNII-F08MQ6CZCS
Benzamide, 3-(cyclopropylmethoxy)-N-(3,5-dichloro-1-oxido-4-pyridinyl)-4-(difluoromethoxy)-
Roflumilast Impurity 6
Top Suppliers:I want be here




Get all suppliers and price by the below link:

Roflumilast N-oxide suppliers


Price: $266/10mM*1mLinDMSO

Reference only. check more Roflumilast N-oxide price